Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 26, Issue 7, 2000, Pages 809-810

  Imoto, S ^a   Murayama, T ^a   Gomyo, H ^a   Mizuno, I ^a   Sugimoto, T ^a   Nakagawa, T ^a   Koizumi, T ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

Acute leukemia; Allogeneic bone marrow transplantation; Donor lymphocyte infusion; Graft versus host disease; Graft versus leukemia effect; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ENOCITABINE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CYTAPHERESIS; DONOR; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFUSION; LIVER; LONG TERM CARE; LYMPHOCYTE; PRIORITY JOURNAL; SKIN; STEROID THERAPY; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0033760548     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702602     Document Type: Article

References (10)

1. Leukemia: Management of relapse after allogeneic bone marrow transplantation
2. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: Results of a survey of 66 cases in 24 Japanese institutes
3. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of GVL responses from GVHD
4. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients
5. Treatment of chronic myelogenous leukemia: Current status and investigational options
6. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
7. Sustained complete cytologic and molecular remission induced by donor leukocyte infusions alone in an acute myeloblastic leukemia in relapse after bone marrow transplantation
8. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation
9. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation
10. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia